Mammalian Cell Fermentation Technology Market Size

Mammalian Cell Fermentation Technology Market size was valued at USD 46.52 billion in 2024 and is likely to cross USD 137.6 billion by the end of 2037, expanding at more than 8.7% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of mammalian cell fermentation technology is assessed at USD 49.76 billion.

The major element to dominate the market revenue is growing cases of COVID-19. Globally COVID-19 cases were close to 767 million as of June 13, 2023. Hence, numerous businesses have shifted their efforts on developing COVID-19 treatments and vaccinations in the wake of the pandemic which is further increasing need for mammalian cell fermentation technology. The increased need for mammalian cells for research and development has resulted in a noteworthy influence on the mammalian cell fermentation industry. 

Furthermore, mammalian cell systems have become popular in the biopharmaceutical business due to strict regulatory rules and safety standards. Since mammalian expression systems may generate big, complex proteins with post-translational modifications (PTMs; most notably glycosylation) the same to those produced in humans, hence further offering greater product consistency and quality, supporting mammalian cell fermentation technology market expansion.